PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 60.74% | 28.16% | 6.54% | 144.63% | -592.21% |
| Total Depreciation and Amortization | -20.55% | 357.89% | -46.15% | -46.09% | -31.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -97.27% | -100.00% |
| Total Other Non-Cash Items | -108.91% | -114.94% | -174.04% | -596.86% | 3,286.97% |
| Change in Net Operating Assets | -3,202.17% | -1,512.35% | 111.26% | 904.29% | 109.34% |
| Cash from Operations | -22.05% | -230.45% | -294.51% | -430.34% | -188.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 148.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -90.42% | 12.90% | -- | -98.82% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.42% | 12.90% | -- | -98.75% | 1,298.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -515.10% | -294.19% | -127.26% | -198.50% | 157.16% |